Author:
Kunte Sophie C.,Toms Johannes,Ledderose Stephan T.,Holzgreve Adrien,Bartenstein Peter,Stief Christian G.,Casuscelli Jozefina,Rodler Severin,Unterrainer Marcus,Staehler Michael,Unterrainer Lena M.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Ahn T, Roberts MJ, Abduljabar A et al (2019) A review of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) in renal cell carcinoma (RCC). Mol Imaging Biol 21:799–807
2. Al-Ahmadie HA, Olgac S, Gregor PD et al (2008) Expression of prostate-specific membrane antigen in renal cortical tumors. Mod Pathol 21:727–732
3. Aytekin A, Aldemir MN, Sakin A et al (2020) Prognostic significance of basal 18F-FDG PET/CT maximum standardized uptake value in patients with metastatic renal cell carcinoma who were treated with sunitinib. J BUON 25:2490–2495
4. Baccala A, Sercia L, Li J et al (2007) Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms. Urology 70:385–390
5. Demirci E, Ocak M, Kabasakal L et al (2014) (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging 41:1461–1462